Chimeric monoclonal antibodies
("-xi-") |
Type |
Name
contains |
Examples
(Clik on the name for more info) |
Tumor |
"-tuxi-" |
Bavituximab,
Brentuximab vedotin,
Cetuximab,
Siltuximab,
Rituximab |
Cardiovascular |
"-cixi-" |
Abciximab,
Volociximab
|
Imune system |
"-lixi-" |
Basiliximab,
Clenoliximab,
Galiximab,
Gomiliximab,
Infliximab,
Keliximab,
Lumiliximab,
Priliximab,
Teneliximab,
Vapaliximab |
Melanoma |
"-mexi-" |
Ecromeximab |
Bacterial |
"-baxi-" |
Pagibaximab |
Humanized monoclonal antibodies
("-zu-") |
Tumor |
"-tuzu-" |
Afutuzumab,
Alemtuzumab,
Bevacizumab,
Bivatuzumab mertansine,
Cantuzumab mertansine,
Citatuzumab bogatox,
Dacetuzumab,
Elotuzumab,
Etaracizumab,
Farletuzumab,
Gemtuzumab ozogamicin,
Inotuzumab ozogamicin,
Labetuzumab,
Lintuzumab,
Matuzumab,
Milatuzumab,
Nimotuzumab,
Oportuzumab monatox,
Pertuzumab,
Sibrotuzumab,
Tacatuzumab tetraxetan,
Tigatuzumab,
Trastuzumab,
Tucotuzumab celmoleukin,
Veltuzumab |
Immune system |
"-lizu-" |
Immunosuppressive:
Aselizumab,
Apolizumab,
Benralizumab,
Cedelizumab,
Certolizumab pegol,
Daclizumab,
Eculizumab,
Efalizumab,
Epratuzumab,
Erlizumab,
Fontolizumab,
Mepolizumab,
Natalizumab,
Ocrelizumab,
Omalizumab,
Pascolizumab,
Pexelizumab,
PRO 140,
Reslizumab,
Rontalizumab,
Rovelizumab,
Ruplizumab,
Siplizumab,
Talizumab,
Teplizumab,
Tocilizumab,
Toralizumab,
Vedolizumab,
Visilizumab,
TGN1412
Non-immunosuppressive:
Ibalizumab |
Bacterial |
"-bazu-" |
Tefibazumab |
Cardiovascular |
"-cizu-" |
Alacizumab pegol,
Bevacizumab/Ranibizumab,
Etaracizumab,
Tadocizumab |
Nervous system |
"-nezu-"/
"-neuzu-" |
Bapineuzumab,
Solanezumab,
Tanezumab |
Toxin target |
"-toxazu-" |
Urtoxazumab |
Viral |
"-vizu-" |
Felvizumab,
Motavizumab,
Palivizumab |
Inerleukin |
"-kizu-" |
Lebrikizumab |
Angiogensis |
"-anibizu-" |
Ranibizumab |
Fully Human monoclonal antibodies
("-u-") |
Tumor |
"-tumu-"/
"-tu-" |
Adecatumumab,
Belimumab,
Cixutumumab,
Conatumumab,
Figitumumab,
Iratumumab,
Lexatumumab,
Lucatumumab,
Mapatumumab,
Necitumumab,
Ofatumumab,
Olaratumab,
Panitumumab,
Pritumumab,
Robatumumab,
Votumumab,
Zalutumumab |
Immune system |
"-limu-" |
Immunosuppression:
Adalimumab, Atorolimumab,
Fresolimumab,
Golimumab,
Lerdelimumab,
Metelimumab,
Morolimumab
immune
Activation:
Ipilimumab, Tremelimumab
Other:
Bertilimumab,
Zanolimumab |
Bacterial |
"-bacu-" |
Nebacumab,
Panobacumab,
Raxibacumab |
Bone |
"-osu- |
Denosumab |
Nervous system |
"-neru-" |
Gantenerumab |
Musculo-skeletal |
"-mulu-" |
Stamulumab |
Viral |
"-viru-" |
Exbivirumab,
Foravirumab,
Libivirumab,
Rafivirumab,
Regavirumab,
Sevirumab,
Tuvirumab |
Inerleukin |
"-kinu-" |
Briakinumab,
Canakinumab,
Ustekinumab |
Fungal |
"-fungu-" |
Efungumab |
Cardiovascular |
"-ciru-" |
Ramucirumab |